The first Iovance Biotherapeutics trade was made in Q3 2019.
Since then Jim Simons bought shares four more times and sold shares on seven occasions. The investor completely sold their stake between Q1 2023 and Q4 2023.
Avg closing price
Price range
Sold -1.23 Million shares
Q4 2023
Avg closing price
$5.23
Price range
$3.30
-
$8.89
Sold 29.2% shares (-506 Thousand shares)
Q3 2023
Avg closing price
$6.53
Price range
$4.44
-
$8.79
Sold 7.6% shares (-143 Thousand shares)
Q2 2023
Avg closing price
$7.16
Price range
$5.36
-
$9.06
Sold 41.4% shares (-1.33 Million shares)
Q1 2023
Avg closing price
$6.90
Price range
$5.53
-
$8.22
Increased shares by 295.9% (+2.39 Million shares)
Q4 2022